Scott Marsh Financial’s Medtronic MDT Stock Holding History

Scott Marsh Financial’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$472K	Buy	+5,418	New	+$459K	0.18%	160

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Scott Marsh Financial's MDT Position: Q2 2025 in Review

Scott Marsh Financial opened a new position in Medtronic (MDT) in Q2 2025: 5,418 shares worth $472K. The stake represents 0.18% of the portfolio and ranks #160 among its holdings.

2,139 funds tracked by Wall St. Rank hold MDT as of Q2 2025.

Scott Marsh Financial held 5,418 shares of Medtronic worth $472K as of Q2 2025.
Medtronic was a new Scott Marsh Financial position in Q2 2025.
Medtronic made up 0.18% of Scott Marsh Financial's portfolio in Q2 2025, its #160 holding.
2,139 funds tracked by Wall St. Rank held Medtronic as of Q2 2025.

Based on Scott Marsh Financial's 13F filing for Q2 2025, filed 14 Aug 2025.